Patent Assignment
Reel/Frame 046491/0017
Security Interest
Recorded: 2018-07-03
Pages: 10
Assignor
OMEROS CORPORATION
Executed: 2018-07-03
Assignee
CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
1000 MAIN STREET, SUITE 2500, HOUSTON, TEXAS, 77002
Covered Properties
(39)
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Application:
15/392,335 →
Publication:
US US20170246150A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
15/391,396 →
Publication:
US US20170166660A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
15/372,054 →
Publication:
US US20170166659A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
PDE10 Inhibitors and Related Compositions and Methods
Application:
15/694,342 →
Publication:
US US20180118711A1
Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation
Application:
15/404,600 →
Publication:
US US20170182007A1
Genetically Modified Non-Human Mammals and Cells
G Protein Coupled Receptor 85 and SREB3 Knockout Mice and Uses Thereof
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
15/347,434 →
Publication:
US US20170137537A1
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
Application:
15/950,633 →
Publication:
US US20180291112A1
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage Associated with Hematopoietic Stem Cell Transplant
Application:
62/630,756 →
Stable Anti-inflammatory Solutions for Injection
Application:
15/885,462 →
Publication:
US US20180344855A1
Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
Stable Preservative-Free Mydriatic and Anti-Inflammatory Solutions for Injection
Application:
15/823,282 →
Publication:
US US20180085349A1
Chimeric Inhibitor Molecules of Complement Activation
Methods for Treating and/or Preventing Graft-Versus-Host Disease
Application:
62/574,690 →
Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions
Application:
15/836,772 →
Publication:
US US20180280350A1
Inhibitors of GPR174 and Uses Thereof
Application:
15/829,830 →
Methods for Reducing Proteinuria in a Human Subject Suffering from Immunoglobulin a Nephropathy
Application:
15/782,627 →
Publication:
US US20180105604A1
Highly Concentrated Low Viscosity Masp-2 Inhibitory Antibody Formulations, Kits, and Methods of Treating Subjects Suffering from Atypical Hemolytic Syndrome
Application:
62/550,328 →
Methods for Treating and/or Preventing Graft-Versus-Host Disease
Application:
62/545,864 →
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
15/909,423 →
Publication:
US US20180291111A1
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-occlusive Disease Associated with Hematopoietic Stem Cell Transplant
Application:
62/637,281 →
Method of Identifying Transmembrane Protein-interacting Compounds
Application:
15/921,371 →
Publication:
US US20180267051A1
Monoclonal Antibodies, Compositions and Methods for Detecting Mucin-Like Protein (Mlp) as a Biomarker for Ovarian and Pancreatic Cancer
Chimeric Inhibitor Molecules of Complement Activation
Masp Isoforms as Inhibitors of Complement Activation
Highly Concentrated Low Viscosity Masp-2 Inhibitory Antibody Formulations, Kits, and Methods
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
Application:
62/527,926 →
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
Application:
15/470,647 →
Publication:
US US20170253667A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Inhibitors of GPR174 and Uses Thereof
Application:
62/513,806 →
Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
Antibodies Specifically Binding to Masp-3 for the Treatment of Various Diseases and Disorders
Methods for Inhibiting Angiogenesis in a Subject in Need Thereof
Solid State Forms of a PDE10 Inhibitor
Chimeric Inhibitor Molecules of Complement Activation
Chimeric Inhibitor Molecules of Complement Activation
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 10, 2017
From: DEMOPULOS, GREGORY A.; DUDLER, THOMAS; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 041977/0983 →
Assignment of Assignor's Interest
Mar 10, 2017
From: SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: UNIVERSITY OF LEICESTER; OMEROS CORPORATION
Reel/Frame 041545/0550 →
Assignment of Assignor's Interest
Mar 23, 2017
From: DEMOPULOS, GREGORY A.; DUDLER, THOMAS; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 041713/0223 →
Assignment of Assignor's Interest
Mar 23, 2017
From: BRUNSKILL, NIGEL JOHN; SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: UNIVERSITY OF LEICESTER; OMEROS CORPORATION
Reel/Frame 041713/0350 →
Assignment of Assignor's Interest
Sep 8, 2017
From: CUTSHALL, NEIL S.; GAGE, JENNIFER LYNN; WHEELER, THOMAS NEIL
To: OMEROS CORPORATION
Reel/Frame 043535/0458 →
Assignment of Assignor's Interest
Sep 14, 2017
From: SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 043594/0505 →
Assignment of Assignor's Interest
Sep 14, 2017
From: DEMOPULOS, GREGORY A.; DUDLER, THOMAS; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 043865/0693 →
Assignment of Assignor's Interest
Nov 9, 2017
From: DEMOPULOS, GREGORY A.; FERGUSON, KENNETH M.; LAMBERT, WILLIAM JOSEPH; WHITAKER, JOHN STEVEN
To: OMEROS CORPORATION
Reel/Frame 044081/0044 →
Assignment of Assignor's Interest
Apr 26, 2018
From: CICIRELLI, MICHAEL; CUTSHALL, NEIL S.; DEMOPULOS, GREGORY A.; GAITANARIS, GEORGE A.
To: OMEROS CORPORATION
Reel/Frame 045649/0953 →
Assignment of Assignor's Interest
Apr 26, 2018
From: DEMOPULOS, GREGORY A.; DUDLER, THOMAS
To: OMEROS CORPORATION
Reel/Frame 045650/0065 →
Assignment of Assignor's Interest
Apr 26, 2018
From: DEMOPULOS, GREGORY A.; DUDLER, THOMAS
To: OMEROS CORPORATION
Reel/Frame 045649/0825 →
Assignment of Assignor's Interest
May 15, 2018
From: DEMOPULOS, GREGORY; DUDLER, THOMAS; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 045812/0319 →
Assignment of Assignor's Interest
May 15, 2018
From: BRUNSKILL, NIGEL JOHN; SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: UNIVERSITY OF LEICESTER; OMEROS CORPORATION
Reel/Frame 046162/0117 →
Assignment of Assignor's Interest
Jul 31, 2018
From: SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: UNIVERSITY OF LEICESTER; OMEROS CORPORATION
Reel/Frame 046516/0890 →
Assignment of Assignor's Interest
Jul 31, 2018
From: DEMOPULOS, GREGORY A.; DUDLER, THOMAS; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 046516/0788 →
Release of Security Interest
Nov 15, 2018
From: CRG SERVICING LLC
To: OMEROS CORPORATION
Reel/Frame 047573/0577 →
Assignment of Assignor's Interest
Apr 29, 2020
From: GARRED, PETER; GLUE, TINA HUMMELSHØJ; SKJØDT, MIKKEL-OLE
To: RIGSHOSPITALET; KØBENHAVNS UNIVERSITET; SYDDANSK UNIVERSITET
Reel/Frame 052522/0414 →
Assignment of Assignor's Interest
Apr 29, 2020
From: SYDDANSK UNIVERSITET
To: RIGSHOSPITALET
Reel/Frame 052522/0502 →
Assignment of Assignor's Interest
Apr 29, 2020
From: RIGSHOSPITALET; UNIVERSITY OF COPENHAGEN
To: OMEROS CORPORATION
Reel/Frame 052522/0593 →
Security Interest
Jun 3, 2024
From: OMEROS CORPORATION
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 067607/0108 →
Corrective Assignment to Correct the Correct the Box Titled"This Document Serves as an Oath/Declaration (37 Cfr 1.63)" Was Erroneously Checked and This Box Should Not Have Been Checked, Previously Recorded at Reel: 67607 Frame: 108. Assignor(S) Hereby Confirms the Security Interest.
Dec 11, 2024
From: OMEROS CORPORATION
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 069715/0719 →
Release of Security Interest
Nov 25, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: OMEROS CORPORATION
Reel/Frame 073705/0970 →